Speciality: Oncology
Description:
Dr. Sushant Mittal kicked off the insightful session titled "CNS Clarity from Day One: Rethinking Early Diagnostic Strategies", joined by esteemed panelists Dr. Tarachand Gupta and Dr. Randeep Singh. The discussion opened with a strong emphasis on the clinical importance of early evaluation for central nervous system (CNS) involvement, especially in complex or aggressive disease presentations. Dr. Mittal highlighted how delays in CNS assessment can result in mismanagement or missed therapeutic windows, setting the tone for a thought-provoking exchange. Dr. Gupta and Dr. Singh added their expertise from neurology and oncology perspectives, offering valuable multidisciplinary insights.
The session explored how CNS evaluation at the time of initial diagnosis is gaining traction in clinical protocols. With advancements in neuroimaging, cerebrospinal fluid analysis, and molecular biomarkers, early detection of CNS disease has become more achievable and actionable. The panel discussed real-world challenges in integrating these strategies, including resource constraints and variability in presentation. Emphasis was placed on identifying high-risk patients early - particularly in oncology and infectious disease contexts - where CNS involvement can significantly affect prognosis and treatment pathways. The conversation also touched on the need for standardized screening protocols and decision-making frameworks that support clinicians across specialties.
Thank you to all who joined this informative session. Your engagement and curiosity continue to drive these meaningful conversations forward. Special thanks to Dr. Sushant Mittal, Dr. Tarachand Gupta, and Dr. Randeep Singh for sharing their expertise. Keep following us for more sessions focused on innovation, interdisciplinary practice, and cutting-edge strategies in healthcare. Together, we’re reshaping how diseases are diagnosed and managed - starting from day one.
See More Webinars @ Hidoc Webinars
1.
Providing essential cancer care to rural communities
2.
Even a few mutated cells can significantly impact how blood cancers develop, study finds
3.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
4.
Treatment of Smoldering Myeloma Cuts Progression Rate in Half
5.
How Do Younger People Fare With Stool Tests for CRC Screening?
1.
Benefits of Neutrophilia: Harnessing the Power of White Blood Cells to Promote Health and Well-Being
2.
Nipple-Sparing Mastectomy: Oncologic Safety and Patient Selection Review
3.
Chemotherapy Advances: Albumin I.V., Trastuzumab, Liposomal Doxorubicin & More
4.
The Truth About Marijuana and Its Effect on Mental Health
5.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation